Finance Home - My Yahoo - Yahoo! - Help

Sunday, December 27, 2009, 5:54PM ET - U.S. Markets Closed. Dow  0.51% Nasdaq  0.71%

Cleveland BioLabs, Inc. (CBLI)

On Dec 24: 3.46   0.10 (2.98%)

MORE ON CBLI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Dec 22, 2009 • Cleveland BioLabs President and CEO Reports Progress on Clinical and Corporate Developments Marketwire (Tue, Dec 22) Mon, Nov 23, 2009 • Cleveland BioLabs Opens Enrollment of Second Safety Study for CBLB502 Marketwire (Mon, Nov 23) Wed, Nov 18, 2009 • Cleveland BioLabs Publishes New Insights Into Mechanism of Action of Curaxins, Extending Their Clinical Potential Marketwire (Wed, Nov 18) • CLEVELAND BIOLABS INC Financials EDGAR Online Financials (Wed, Nov 18) Thu, Nov 12, 2009 • CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 12) Mon, Nov 2, 2009 • Cleveland BioLabs to Present at Merriman 6th Annual Investor Summit Marketwire (Mon, Nov 2) Tue, Oct 20, 2009 • Cleveland BioLabs to Host Roundtable on Protectan CBLB502 for Acute Radiation Syndrome Marketwire (Tue, Oct 20) Mon, Oct 19, 2009 • Cleveland BioLabs to Present at 8th Annual BIO Investor Forum Marketwire (Mon, Oct 19) Tue, Oct 6, 2009 • Department of Defense Increases Ongoing Contract With Cleveland BioLabs for Developmental Studies Related to Protectan CBLB502 Marketwire (Tue, Oct 6) Mon, Oct 5, 2009 • Rodman & Renshaw Initiates Analyst Coverage of Cleveland BioLabs Marketwire (Mon, Oct 5) Wed, Sep 30, 2009 • Cleveland BioLabs keeps cashing in at bizjournals.com (Wed, Sep 30) • Armed Forces Radiobiology Research Institute and Cleveland BioLabs Awarded Grant From Department of Defense to Study Radioprotective Effects of Protectan CBLB600 Series Marketwire (Wed, Sep 30) Tue, Sep 29, 2009 • More cancer funds for Cleveland BioLabs at bizjournals.com (Tue, Sep 29) • Coverage initiated on Cleveland Biolabs by Rodman & Renshaw Briefing.com (Tue, Sep 29) • Cleveland BioLabs Awarded $5.3 Million Grand Opportunities Grant From National Institutes of Health for Protectan CBLB502 Research in Mitigation of Radiation Damage of GI Tract Marketwire (Tue, Sep 29) Thu, Sep 24, 2009 • Cleveland BioLabs Receives $2.3 Million Addition to $13.3 Million Contract With Biomedical Advanced Research and Development Authority (BARDA) to Develop Radiation Countermeasure Protectan CBLB502 Marketwire (Thu, Sep 24) Tue, Sep 22, 2009 • National Institute of Allergy and Infectious Diseases Awards Cleveland BioLabs Additional Grant for Protectan CBLB502 Research in Mitigation of Radiation Damage Marketwire (Tue, Sep 22) Mon, Sep 21, 2009 • Cleveland BioLabs to Present at Maxim Group Growth Conference Marketwire (Mon, Sep 21) Wed, Sep 9, 2009 • CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi EDGAR Online (Wed, Sep 9) • Cleveland BioLabs and Zhejiang Hisun Pharmaceutical Enter License Agreement for Protectan CBLB612 Hematopoietic Stem Cell Stimulator and Mobilizer in China Marketwire (Wed, Sep 9) Older Headlines - Download Recent Headlines View headlines from: Wed, Sep 9, 2009Wed, Sep 2, 2009Wed, Aug 26, 2009Wed, Aug 19, 2009Wed, Aug 12, 2009Wed, Aug 5, 2009Wed, Jul 29, 2009Wed, Jul 22, 2009Wed, Jul 15, 2009Wed, Jul 8, 2009 Add CBLI News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage